Precision Medicine in Osteosarcoma: MATCH Trial and Beyond

Osteosarcoma (OS) is a rare bone malignant tumour with a poor prognosis in the case of recurrence. So far, there is no agreement on the best systemic therapy for relapsed OS. The availability of next generation sequencing techniques has recently revolutionized clinical research. The sequencing of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tirtei, Elisa, Campello, Anna, Asaftei, Sebastian D., Mareschi, Katia, Cereda, Matteo, Fagioli, Franca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911557/
https://www.ncbi.nlm.nih.gov/pubmed/33572496
http://dx.doi.org/10.3390/cells10020281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911557/
https://www.ncbi.nlm.nih.gov/pubmed/33572496
http://dx.doi.org/10.3390/cells10020281

Ejemplares similares